Literature DB >> 10993775

Left ventricular wall stress normalization in chronic pressure-overloaded heart: a mathematical model study.

P Segers1, N Stergiopulos, J J Schreuder, B E Westerhof, N Westerhof.   

Abstract

It is generally accepted that the left ventricle (LV) hypertrophies (LVH) to normalize systolic wall stress (sigma(s)) in chronic pressure overload. However, LV filling pressure (P(v)) may be elevated as well, supporting the alternative hypothesis of end-diastolic wall stress (sigma(d)) normalization in LVH. We used an LV time-varying elastance model coupled to an arterial four-element lumped-parameter model to study ventricular-arterial interaction in hypertension-induced LVH. We assessed model parameters for normotensive controls and applied arterial changes as observed in hypertensive patients with LVH (resistance +40%, compliance -25%) and assumed 1) no cardiac adaptation, 2) normalization of sigma(s) by LVH, and 3) normalization of sigma(s) by LVH and increase in P(v), such that sigma(d) is normalized as well. In patients, systolic and diastolic blood pressures increase by approximately 40%, cardiac output (CO) is constant, and wall thickness increases by 30-55%. In scenarios 1 and 2, blood pressure increased by only 10% while CO dropped by 20%. In scenario 2, LV wall thickness increased by only 10%. The predictions of scenario 3 were in qualitative and quantitative agreement with in vivo human data. LVH thus contributes to the elevated blood pressure in hypertension, and cardiac adaptations include an increase in P(v), normalization of sigma(s), and preservation of CO in the presence of an impaired diastolic function.

Entities:  

Mesh:

Year:  2000        PMID: 10993775     DOI: 10.1152/ajpheart.2000.279.3.H1120

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

Review 1.  Biomechanics of Cardiac Function.

Authors:  Andrew P Voorhees; Hai-Chao Han
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

2.  Modeling the instantaneous pressure-volume relation of the left ventricle: a comparison of six models.

Authors:  Jan-Willem Lankhaar; Fleur A Rövekamp; Paul Steendijk; Theo J C Faes; Berend E Westerhof; Taco Kind; Anton Vonk-Noordegraaf; Nico Westerhof
Journal:  Ann Biomed Eng       Date:  2009-06-25       Impact factor: 3.934

Review 3.  Review of zero-D and 1-D models of blood flow in the cardiovascular system.

Authors:  Yubing Shi; Patricia Lawford; Rodney Hose
Journal:  Biomed Eng Online       Date:  2011-04-26       Impact factor: 2.819

4.  Loss of talin in cardiac fibroblasts results in augmented ventricular cardiomyocyte hypertrophy in response to pressure overload.

Authors:  Natalie A Noll; Lance A Riley; Christy S Moore; Lin Zhong; Mathew R Bersi; James D West; Roy Zent; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

5.  Passive and active ventricular elastances of the left ventricle.

Authors:  Liang Zhong; Dhanjoo N Ghista; Eddie Y K Ng; Soo T Lim
Journal:  Biomed Eng Online       Date:  2005-02-11       Impact factor: 2.819

Review 6.  Treatment strategies for the right heart in pulmonary hypertension.

Authors:  Berend E Westerhof; Nabil Saouti; Willem J van der Laarse; Nico Westerhof; Anton Vonk Noordegraaf
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

7.  Non-linearity of end-systolic pressure-volume relation in afterload increases is caused by an overlay of shortening deactivation and the Frank-Starling mechanism.

Authors:  Moriz A Habigt; Michelle Krieger; Jonas Gesenhues; Maike Ketelhut; Mare Mechelinck; Marc Hein
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

8.  Contribution of the Arterial System and the Heart to Blood Pressure during Normal Aging - A Simulation Study.

Authors:  Elira Maksuti; Nico Westerhof; Berend E Westerhof; Michael Broomé; Nikos Stergiopulos
Journal:  PLoS One       Date:  2016-06-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.